About Hospital da Universidade Federal de Santa Maria CEP/UFSM
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clover Biopharmaceuticals AUS Pty Ltd
1
F2G Biotech GmbH
1
Clinical Trials at Hospital da Universidade Federal de Santa Maria CEP/UFSM
During the past decade, Hospital da Universidade Federal de Santa Maria CEP/UFSM conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options
2018-06-06
2023-04-01
Recruiting
200
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19
2021-03-24
2023-04-01
Active, not recruiting
31,454
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital da Universidade Federal de Santa Maria CEP/UFSM"
#1 collaborator was "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator, "International Vaccine Institute" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Hospital da Universidade Federal de Santa Maria CEP/UFSM
According to Clinical.Site data, the most researched conditions in "Hospital da Universidade Federal de Santa Maria CEP/UFSM" are
"COVID-19" (1 trials) and "Invasive Fungal Infections" (1 trials). Many other conditions were trialed in "Hospital da Universidade Federal de Santa Maria CEP/UFSM" in a lesser frequency.
Clinical Trials Intervention Types at Hospital da Universidade Federal de Santa Maria CEP/UFSM
Most popular intervention types in "Hospital da Universidade Federal de Santa Maria CEP/UFSM" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "CpG 1018/Alum-adjuvanted SCB-2019 vaccine" (1 trials), "F901318" (1 trials), "Placebo; 0.9% saline" (1 trials), "SCB-2019 vaccine" (1 trials) and "SCB-2019 vaccine for Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital da Universidade Federal de Santa Maria CEP/UFSM
The vast majority of trials in "Hospital da Universidade Federal de Santa Maria CEP/UFSM" are
2 trials for "All" genders.
Clinical Trials Status at Hospital da Universidade Federal de Santa Maria CEP/UFSM
Currently, there are NaN active trials in "Hospital da Universidade Federal de Santa Maria CEP/UFSM".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Hospital da Universidade Federal de Santa Maria CEP/UFSM,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital da Universidade Federal de Santa Maria CEP/UFSM, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".